Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9401

Full metadata record

DC Field	Value	Language
dc.contributor.author	Chen, Po-Sung	-
dc.contributor.author	Lee, Ju	-
dc.contributor.author	Pan, Hui-Ping	-
dc.contributor.author	Lin, Yuh-Jyh	-
dc.contributor.author	Lin, Yung-Chieh	-
dc.contributor.author	Chang, Yu-Shan	-
dc.date.accessioned	2024-12-20T01:55:38Z	-
dc.date.available	2024-12-20T01:55:38Z	-
dc.date.issued	2023-08	-
dc.identifier.citation	Short Communication	en_US
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/9401	-
dc.description.abstract	Abstract From 2011, 37 children were referred to a hospital due to low levels of T cell receptor excision circles (TRECs) from newborn screening. Among them, three children were immunologically characterized and followed up to show that postnatal corticosteroid usage may be among the causes of false positivity in TRECs screening.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Elsevier Taiwan LLC	en_US
dc.subject	Corticosteroid	en_US
dc.subject	Severe combined immunodeficiency	en_US
dc.subject	SCID	en_US
dc.subject	False positive	en_US
dc.subject	Newborn screening	en_US
dc.title	Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening	en_US
dc.type	Article	en_US
Appears in Collections:	VOL 56 NO 4 2023

Files in This Item:

File	Description	Size	Format
871-874.pdf		307.46 kB	Adobe PDF	View/Open

DSpace JSPUI